United States

Showing 281-290 of 345 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
In vivo interactions and trafficking of islet antigen-specific human effector T cells and Tregs	University of Massachusetts Medical School	Michael Brehm	Cures	01-November-2024 to 31-October-2027	$825,000.00
Artificial Intelligence-driven redesign of beta cell regulatory logic for resilience to inflammation	University of Massachusetts Medical School	Rene Maehr	Cures	01-April-2026 to 31-March-2027	$199,999.88
Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement	University of Miami	Alice Tomei	Cures	01-February-2024 to 31-January-2027	$750,000.00
Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity	University of Miami	Dhanashree Surve	Cures	01-March-2026 to 28-February-2029	$274,010.00
Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas	University of Miami	Dirk Homann	Cures	01-April-2025 to 31-March-2027	$53,972.92
Preclinical development of the BMP receptor agonist THR-184 for beta cell regeneration	University of Miami	Juan Dominguez-Bendala	Cures	01-April-2024 to 31-March-2027	$741,000.00
Role of pericytes during type 1 diabetes pathogenesis	University of Miami	Luciana Mateus Goncalves	Cures	01-March-2024 to 28-February-2027	$259,750.00
Modulate beta cell proliferation and immunogenicity via aptamer-decorated lipid nanoparticles	University of Miami	Paolo Serafini	Cures	01-April-2023 to 31-March-2027	$894,602.00
bifunctional RNA therapeutics for T1D	University of Miami	Paolo Serafini	Cures	01-February-2025 to 31-January-2028	$900,000.00
Enhance β-Cell Replacement Therapies via Localized Immune Modulation Using DIANA Nanocarriers	University of Miami	Peter Buchwald	Cures	01-September-2023 to 31-August-2026	$900,000.00